These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11505622)

  • 21. Impact of the interfraction interval on clonogenic cell survival in split-dose irradiation of R1H rhabdomyosarcoma of the rat in vitro.
    Willers H; Prosch B; Beck-Bornholdt HP
    Radiother Oncol; 1997 Apr; 43(1):93-6. PubMed ID: 9165143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation--126 fractions applied within 6 weeks.
    Beck-Bornholdt HP; Maurer T; Becker S; Omniczynski M; Vogler H; Würschmidt F
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):701-5. PubMed ID: 2921168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of radiosensitivity of rat rhabdomyosarcoma R1H with normobaric carbogen and hyperbaric oxygen (HBO) using conventionally fractionated irradiation.
    Hartmann KA; Carl UM; Plugge DC; Schneider CJ; Sminia P
    Br J Radiol; 1998 Apr; 71(844):433-7. PubMed ID: 9659137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygenation of tumor recurrences following fractionated radiotherapy of primary tumors. Studies on the rhabdomyosarcoma R1H of the rat.
    Kehrl W; Sagowski C; Wenzel S; Zywietz F
    Strahlenther Onkol; 2004 Jun; 180(6):383-90. PubMed ID: 15175874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initially accelerated fractionation of the R1H tumor of the rat increases local tumor control and might reduce impact of overall treatment time.
    Raabe A; Petersen C; Krüll A
    Strahlenther Onkol; 2007 Jul; 183(7):360-5. PubMed ID: 17609868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative changes of metabolic and bioenergetic parameters in experimental tumors during fractionated irradiation.
    Thews O; Zywietz F; Lecher B; Vaupel P
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1281-8. PubMed ID: 10613324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H.
    Hartmann KA; van der Kleij AJ; Carl UM; Hulshof MC; Willers R; Sminia P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1037-44. PubMed ID: 11704328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined modality treatment of the rhabdomyosarcoma R1H of the rat: influence of sequence of cisplatin and fractionated irradiation.
    Würschmidt F
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):73-8. PubMed ID: 8416884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation.
    Beck-Bornholdt HP; Omniczynski M; Theis E; Vogler H; Würschmidt F
    Acta Oncol; 1991; 30(1):57-63. PubMed ID: 2009185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiobiological determination of growth kinetics and radiosensitivity of pulmonary micrometastases of the R1H tumour.
    Raabe A; Beck-Bornholdt HP
    Radiother Oncol; 1994 Mar; 30(3):254-62. PubMed ID: 8209010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined modality treatment of the rhabdomyosarcoma R1H of the rat: tumor and normal tissue response after cisplatin and conventional or accelerated irradiation treatment.
    Würschmidt F; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):391-4. PubMed ID: 7751181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy of the rhabdomyosarcoma R1H of the rat: postoperative radiotherapy.
    Carl UM; Beck-Bornholdt HP; Baumann M; Lorenzen J; Vogler H
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):883-6. PubMed ID: 2323976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
    De Wit M; Raabe A; Seegers B; Buchert R; Beck-Bornholdt HP; Alberti W; Hossfeld DK
    Int J Radiat Biol; 2004 Jul; 80(7):529-39. PubMed ID: 15360091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depopulation and repopulation of the R1H rhabdomyosarcoma of the rat after X-irradiation.
    Jung H; Beck HP; Brammer I; Zywietz F
    Eur J Cancer (1965); 1981 Apr; 17(4):375-86. PubMed ID: 7308250
    [No Abstract]   [Full Text] [Related]  

  • 35. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA; Millar WT; Visser AG; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiosensitizing effect of carbogen breathing during pulsed irradiation of the rat R1H tumor.
    Sminia P; Hartmann KA; Schneider CJ; Carl UM; van der Kleij AJ; Slotman BJ; Huishof MC
    Acta Oncol; 2001; 40(7):870-4. PubMed ID: 11859988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line.
    Hermens AF; Bentvelzen PA
    Cancer Res; 1992 Jun; 52(11):3073-82. PubMed ID: 1591720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric determination of the time of metastasis during fractionated radiation therapy of the rat rhabdomyosarcoma R1H.
    Baumann M; Becker S; Krüger HJ; Vogler H; Maurer T; Beck-Bornholdt HP
    Int J Radiat Biol; 1990 Aug; 58(2):361-9. PubMed ID: 1974582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.